Aromatase Inhibitors and Joint Pain Medscape CME

Description: Upon completion of this activity, participants will be able to:
Describe the prevalence and location of arthralgias among women taking aromatase inhibitors.
Describe synovial, electromyographic, and inflammatory marker changes associated with use of aromatase inhibitors.
One third of postmenopausal women with breast cancer taking aromatase inhibitors (AIs) reported arthralgia — either new onset or worsening, according to investigators of a new study published online September 14 in the Journal of Clinical Oncology